» Articles » PMID: 29697154

A Phase-by-Phase Review of Migraine Pathophysiology

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 2018 Apr 27
PMID 29697154
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is a common, disabling neurological disorder characterized by multiple phases: premonitory, aura, headache, postdrome, and interictal. Our understanding of the pathophysiology of each phase of migraine has evolved over recent years. The premonitory phase begins as early as 3 days before the headache phase, and involves a complex interplay between various cortical and subcortical brain regions, including the hypothalamus and brainstem nuclei that modulate nociceptive signaling. The headache phase involves activation of the trigeminovascular system, a pathway that is well characterized. In one-third of patients, an aura phase may occur during some attacks and likely correlates with a cortical spreading depression-like event; a slowly propagating wave of neuronal and glial cell depolarization and hyperpolarization. Improved characterization of the pathophysiological processes involved at each stage of the migraine attack will aid the identification of new therapeutic targets for migraine prevention. This review provides an update on prevailing concepts of migraine pathophysiology.

Citing Articles

Up-regulation of MAPK14-related lncRNAs in the circulation of migraineurs.

Talemi F, Hussen B, Keshmir F, Movafagh A, Sarabi P, Rahmanian M Sci Rep. 2025; 15(1):7250.

PMID: 40021777 PMC: 11871286. DOI: 10.1038/s41598-025-91943-8.


Bridging Gaps in Migraine Management: A Comprehensive Review of Conventional Treatments, Natural Supplements, Complementary Therapies, and Lifestyle Modifications.

Abo-Elghiet F, Elosaily H, Hussein D, El-Shiekh R, Aaqoulah A, Yousef E Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005953 PMC: 11858087. DOI: 10.3390/ph18020139.


Serial systemic immune inflammation indices: markers of acute migraine events or indicators of persistent inflammatory status?.

Wijeratne T, Murphy M, Wijeratne C, Martelletti P, Karimi L, Apostolopoulos V J Headache Pain. 2025; 26(1):7.

PMID: 39794705 PMC: 11721065. DOI: 10.1186/s10194-024-01929-6.


Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members' vision - part 2.

Petrusic I, Chiang C, Garcia-Azorin D, Ha W, Ornello R, Pellesi L J Headache Pain. 2025; 26(1):2.

PMID: 39748331 PMC: 11697626. DOI: 10.1186/s10194-024-01944-7.


Botulinum Toxin and Migraine: Goals and Perspectives.

Prudenzano M Toxins (Basel). 2024; 16(12).

PMID: 39728788 PMC: 11679156. DOI: 10.3390/toxins16120530.